Sol-Gel Technologies (SLGL) Profit After Tax (2017 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Profit After Tax came in at $1.31 in Q1 2026, down 59.06% year-on-year from $3.2 in Q1 2025, and up 100.0% on a QoQ basis from -$3.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Profit After Tax (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Profit After Tax data on file, last reported at $1.31 in Q1 2026.
- On a quarterly basis, Profit After Tax fell 59.06% year-over-year to $1.31 in Q1 2026; TTM through Mar 2026 was $14.6 million, a 206.28% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, up 42.09% from the prior year.
- Profit After Tax for Q1 2026 stood at $1.31, up from -$3.0 million in the prior quarter.
- Over the last five years, Profit After Tax for SLGL reached as high as $11.6 million in Q2 2025 and fell as low as -$15.3 million in Q4 2024.
- Historically, Profit After Tax has averaged -$1.1 million across 5 years, with a median of $0.24 in 2022.
- On a YoY basis, Profit After Tax climbed as much as 59699999900.0% in 2023 and fell as far as 3807333233.33% in 2023.
- Year by year, Profit After Tax stood at -$14.9 million in 2022, then jumped by 67.59% to -$4.8 million in 2023, then plunged by 216.67% to -$15.3 million in 2024, then surged by 80.49% to -$3.0 million in 2025, then surged by 100.0% to $1.31 in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $1.31 in Q1 2026, -$3.0 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Sol-Gel Technologies | 234.04 Mn | 223.91 Mn | - | 1.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | -2.99 Mn |
| Sep 30, 2025 | 5.94 Mn |
| Jun 30, 2025 | 11.61 Mn |
| Mar 31, 2025 | 3.20 |
| Dec 31, 2024 | -15.31 Mn |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 2.30 |
| Dec 31, 2023 | -4.84 Mn |
| Sep 30, 2023 | -5.71 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | -14.92 Mn |
| Sep 30, 2022 | -0.15 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.24 |
| Dec 31, 2021 | 14.03 Mn |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 0.35 |